COMMUNIQUÉS West-GlobeNewswire

G1 Therapeutics to Present Preliminary Data from Randomized Phase 2 Trial of Trilaciclib in Metastatic Triple-Negative Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

10/11/2018 - 01:40

RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that preliminary data from its randomized Phase 2 clinical trial [...]

Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for KAIYADRU®. Hoverink Biotechnologies, Inc plans to develop and commercialize KAIYADRU®

10/11/2018 - 00:42

Overview On September 26, 2018 We filed trademark applications covering: LOS ANGELES, CA, Nov. 09, 2018 (GLOBE NEWSWIRE) -- KAIYADRU® Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of [...]

HEXO announces filing of preliminary base shelf prospectus

09/11/2018 - 23:54

GATINEAU, Quebec, Nov. 09, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities [...]

HEXO annonce le dépôt d’un prospectus préalable de base provisoire

09/11/2018 - 23:54

GATINEAU, Québec, 09 nov. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO) a annoncé le dépôt d’un prospectus préalable de base simplifié provisoire auprès des autorités de réglementation en [...]

MacroGenics Reports Presentation of Clinical Data at 33rd Annual SITC Meeting

09/11/2018 - 23:30

Enoblituzumab + pembrolizumab combination study data reported: ORRs in anti-PD-1/PD-L1 naïve SCCHN and NSCLC cohorts benchmarked favorably vs. approved anti-PD-1 agents Interim data from Phase 1 dose expansion study of [...]

Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business Update

09/11/2018 - 22:46

SAN DIEGO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third quarter ended September 30, 2018 and a business update. Dr. Dennis J. Carlo [...]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

09/11/2018 - 22:45

Conference Call Scheduled for Monday, November 12 th at 11:30 AM EST NORTHVALE, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]

Atrion Reports Third Quarter Results

09/11/2018 - 22:30

ALLEN, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2018 revenues totaled $39.3 million, up from $37.9 million for the same [...]

Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights

09/11/2018 - 22:20

Investor Conference Call on Monday, November 12 th at 10:00 a.m. ET NEW YORK and CLEVELAND, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company [...]

Asterias Biotherapeutics Reports Third Quarter Results

09/11/2018 - 22:10

Clinical Programs Continue to Progress Recent Transactions with affiliate of Novo Nordisk Increased Cash-on-Hand and Reduced Annual Operating Expenses Recently Announced Definitive Merger Agreement with BioTime Creates [...]

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09/11/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]

Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

09/11/2018 - 22:01

Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Corporate Development and IT & Database Administrator NEWTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc [...]

athenahealth Reports Third Quarter Fiscal Year 2018 Results

09/11/2018 - 22:01

Company Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading provider of network-enabled services for [...]

OPKO Health Reports Third Quarter 2018 Financial Results

09/11/2018 - 22:01

Conference Call begins today at 4:15 p.m. Eastern Time MIAMI , Nov. 09, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended September 30, [...]

LeMaitre Vascular to Present at Upcoming Investor Conferences

09/11/2018 - 21:45

BURLINGTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in November. David Roberts, President, is scheduled to present at [...]

TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting

09/11/2018 - 21:41

Initial data from AMBER trial of TSR-022 (anti-TIM-3) in combination with TSR-042 (anti-PD-1) demonstrated clinical activity in patients who have progressed following anti-PD-1 treatment TSR-042 monotherapy demonstrated [...]

Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium

09/11/2018 - 20:31

Initiating Phase 1 ATTCK-34-01 Trial in HER2+ Advanced Cancers by Year-End CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on [...]

Adamas to Present at Three November Investor Conferences

09/11/2018 - 19:49

EMERYVILLE, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]

Unilever and Bio-on work together to reduce environmental impact in the Personal Care sector

09/11/2018 - 18:35

Rome (Italy), 9 November 2018 - Unilever and Bio-on announce the start of a strategic partnership to develop, produce and sell personal hygiene and care products that guarantee a smaller or no environmental impact. [...]